Cargando…
Partial response of donafenib as the third-line therapy in metastatic colon cancer: A case report
RATIONALE: Colorectal cancer (CRC) is a digestive tumor with high morbidity and mortality rates. After second-line treatment failure, third-line treatment options are limited, and the objective response rate is low. These patients are expected to have a short survival time. Therefore, it is very imp...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447981/ https://www.ncbi.nlm.nih.gov/pubmed/34664852 http://dx.doi.org/10.1097/MD.0000000000027204 |